Medicare Enrolled

Dr. Katherine Labiner, MD

Epilepsy Physician · Austin, TX
5301 DAVIS LN BLDG A200, Austin, TX 78749
5124944000
Registered in NPPES since 2011
NPI: 1861788465 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Labiner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Labiner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Labiner

Dr. Katherine Labiner is an epilepsy physician in Austin, TX, with 15 years of NPI registration.

Between the years covered by Open Payments, Dr. Labiner received a total of $86,646 from 66 pharmaceutical and/or device companies across 793 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Labiner is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration $86,646 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$86,646
Total received (2018-2024)
Avg $12,378/year across 7 years
Top 3% in TX for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
793
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$66,522
2023
$4,884
2022
$5,775
2021
$1,627
2020
$3,267
2019
$3,257
2018
$1,314

Payments by company (2024)

ACADIA Pharmaceuticals Inc
$28,383
UCB, Inc.
$21,242
Otter Pharmaceuticals, LLC
$7,104
Neurelis, Inc.
$3,894
JAZZ PHARMACEUTICALS INC.
$3,176
SK Life Science, Inc.
$1,027
Pyros Pharmaceuticals, Inc.
$199
IRONSHORE PHARMACEUTICALS INC.
$164
BIOCODEX, INC.
$153
Tris Pharma Inc
$150
Abbott Laboratories
$117
Aucta Pharmaceuticals, Inc.
$112
Corium, LLC
$108
NEUROPACE, INC.
$88
UPSHER-SMITH LABORATORIES LLC
$87
AQUESTIVE THERAPEUTICS, INC.
$72
Marinus Pharmaceuticals, Inc.
$59
Neos Therapeutics, LP
$51
Vertical Pharmaceuticals, LLC
$46
ABBVIE INC.
$40
ITF Therapeutics LLC
$35
CATALYST PHARMACEUTICALS, INC.
$33
Mallinckrodt Hospital Products Inc.
$30
Biogen, Inc.
$29
Supernus Pharmaceuticals, Inc.
$27
Avion Pharmaceuticals
$21
PIRAMAL CRITICAL CARE
$20
LivaNova USA, Inc.
$19
GENZYME CORPORATION
$18
Amgen Inc.
$17
Top 3 companies account for 85.3% of 2024 payments
All-time payments by company (2018-2024) ›
ACADIA Pharmaceuticals Inc
$28,535
UCB, Inc.
$23,142
Otter Pharmaceuticals, LLC
$7,104
AQUESTIVE THERAPEUTICS, INC.
$6,840
Neurelis, Inc.
$4,603
JAZZ PHARMACEUTICALS INC.
$3,410
SK Life Science, Inc.
$2,855
LivaNova USA, Inc.
$1,532
Greenwich Biosciences, Inc.
$816
Tris Pharma Inc
$627
Jazz Pharmaceuticals Inc.
$605
NEUROPACE, INC.
$513
Takeda Pharmaceuticals U.S.A., Inc.
$447
UPSHER-SMITH LABORATORIES LLC
$442
Supernus Pharmaceuticals, Inc.
$438
NeuroPace, Inc.
$277
Corium, LLC
$263
Amgen Inc.
$226
Sunovion Pharmaceuticals Inc.
$223
Pyros Pharmaceuticals, Inc.
$217
Ipsen Biopharmaceuticals, Inc
$217
EISAI INC.
$214
Neos Therapeutics, LP
$214
Zogenix Inc.
$208
Abbott Laboratories
$183
IRONSHORE PHARMACEUTICALS INC.
$164
Ironshore Pharmaceuticals Inc.
$164
BIOCODEX, INC.
$153
Sumitomo Pharma America, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$127
GlaxoSmithKline, LLC.
$122
Aucta Pharmaceuticals, Inc.
$112
Biocodex, Inc.
$109
Upsher-Smith Laboratories LLC
$107
Vertical Pharmaceuticals, LLC
$84
Marinus Pharmaceuticals, Inc.
$83
Biohaven Pharmaceutical Holding Company Ltd.
$81
ABBVIE INC.
$78
Saol Therapeutics Inc.
$76
Biogen, Inc.
$74
Aquestive Therapeutics, Inc.
$62
Antares Pharma, Inc.
$61
Shire North American Group Inc
$56
Merz Pharmaceuticals, LLC
$52
Mallinckrodt Hospital Products Inc.
$45
Eisai Inc.
$43
Amneal Pharmaceuticals LLC
$41
Corium, Inc.
$39
GENZYME CORPORATION
$37
Avion Pharmaceuticals
$35
ITF Therapeutics LLC
$35
PIRAMAL CRITICAL CARE
$34
CATALYST PHARMACEUTICALS, INC.
$33
PTC Therapeutics, Inc.
$28
TerSera Therapeutics LLC
$25
E.R. Squibb & Sons, L.L.C.
$25
Adlon Therapeutics L.P.
$24
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$21
Octapharma USA, Inc.
$21
Janssen Biotech, Inc.
$20
Novartis Pharmaceuticals Corporation
$19
ARBOR PHARMACEUTICALS, INC.
$16
Aprecia Pharmaceuticals, LLC
$14
Genentech USA, Inc.
$13
NOBELPHARMA AMERICA, LLC
$12
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 67.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADHANSIA XR · APTIOM · AZSTARYS · Adzenys XR-ODT · Azstarys · BENLYSTA · BOTOX · Briviact · Cenobamate · Cotempla XR-ODT · DAYBUE · DIACOMIT · DYSPORT · Dyanavel XR · Dysport · EMFLAZA · EPIDIOLEX · Edarbi · Enbrel · Epidiolex · Evekeo · FYCOMPA · Fintepla · Fycompa · GABLOFEN · HYFTOR · ILARIS · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LIBERVANT · Lioresal (baclofen) · METHYLPHENIDATE 72 · Methylphenidate Hydrochloride · Motpoly XR · NURTEC ODT · Nayzilam · OCTRODE · ORENCIA · OTREXUP · OXTELLAR XR · PANZYGA · QELBREE · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · Qelbree · Quzyttir · RELEXXII · RNS Neurostimulator Kit · RNS System · Relexxii · SIMPONI · SKYCLARYS · SPINRAZA · SYMPAZAN · Spritam · Sympazan · TORPENZ · TROKENDI XR · VALTOCO · VIGADRONE · VIGADRONE (VIGABATRIN) FOR ORAL SOLUTION · VIGADRONE (vigabatrin) for Oral Solution · VIGPODER · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VYVANSE · Vyvanse · XCOPRI · XYREM · Xeomin · ZOLGENSMA · ZOMIG · ZTALMY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an epilepsy physician in Austin?
Compare epilepsy physicians in the Austin area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians in nearby ZIP areas
4
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
AUSTIN OAKS HOSPITAL
3.5 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Labiner is an epilepsy physician, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Labiner receive payments from pharmaceutical companies?
Yes. Dr. Labiner received a total of $86,646 from 66 companies across 793 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Labiner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Epilepsy Physicians in Austin
Browse epilepsy physicians in Austin ranked by procedure volume and transparency data.
Highest volume
Top Epilepsy Physicians in TX
Epilepsy physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Epilepsy Physicians in TX
Which TX epilepsy physicians receive the most from drug and device companies.
By company
ACADIA Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from ACADIA Pharmaceuticals Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Otter Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Otter Pharmaceuticals, LLC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →